Novel mutations in the Wiskott‐Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes

Wiskott‐Aldrich syndrome (WAS) is an X‐linked recessive immunodeficiency characterized by thrombocytopenia, eczema, and recurrent infections, and caused by mutations in the WAS protein (WASP) gene. WASP contains several functional domains through which it interacts with proteins involved in intracellular signaling and regulation of the actin cytoskeleton. In this report, 17 WASP gene mutations were identified, 12 of which are novel. DNA of affected males and obligate carriers was PCR amplified and analyzed by SSCA, heteroduplex analysis, and direct sequencing. The effects of the mutations at the mRNA and protein level were ascertained by RT‐PCR and Western blot analyses. All missense mutations were located in exons 1–4. Most of the nonsense, frameshift and splice site mutations were found in exons 6–11. Mutations that alter splice sites led to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product. The presence of normally spliced transcripts was correlated with a milder phenotype. When one such case was studied by Western blotting, reduced amounts of normal‐size WASP were present. In other cases as well, a correlation was found between the amount of normal or mutant WASP present and the phenotypes of the affected individuals. No protein was detected in two individuals with severe WAS. Reduced levels of a normal‐size WASP with a missense mutation were seen in two individuals with XLT. It is concluded that mutation analysis at the DNA level is not sufficient for predicting clinical course. Studies at the transcript and protein level are needed for a better assessment. Hum Mutat 14:54–66, 1999. © 1999 Wiley‐Liss, Inc.

[1]  H. Ochs.  The Wiskott-Aldrich syndrome. , 1998, Clinical reviews in allergy & immunology.

[2]  H. Ochs,et al.  Collagen induces tyrosine phosphorylation of Wiskott-Aldrich syndrome protein in human platelets. , 1998, Blood.

[3]  P. Chavrier,et al.  Tyrosine phosphorylation of the Wiskott‐Aldrich Syndrome protein by Lyn and Btk is regulated by CDC42 , 1998, FEBS letters.

[4]  R. Badolato,et al.  Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. , 1998, Journal of immunology.

[5]  C. Kinnon,et al.  Absence of expression of the Wiskott-Aldrich syndrome protein in peripheral blood cells of Wiskott-Aldrich syndrome patients. , 1998, Clinical immunology and immunopathology.

[6]  T. Kirchhausen.  Wiskott-Aldrich syndrome: a gene, a multifunctional protein and the beginnings of an explanation. , 1998, Molecular medicine today.

[7]  Dunn,et al.  Chemotaxis of macrophages is abolished in the Wiskott‐Aldrich syndrome , 1998, British journal of haematology.

[8]  L. Notarangelo,et al.  Defective actin polymerization in EBV‐transformed B‐cell lines from patients with the Wiskott–Aldrich syndrome , 1998, The Journal of pathology.

[9]  Yan Wu,et al.  Tyrosine Phosphorylation Regulates the SH3-mediated Binding of the Wiskott-Aldrich Syndrome Protein to PSTPIP, a Cytoskeletal-associated Protein* , 1998, The Journal of Biological Chemistry.

[10]  T. Takenawa,et al.  Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization. , 1998, Biochemical and biophysical research communications.

[11]  O. Haas,et al.  X-linked Wiskott-Aldrich syndrome in a girl. , 1998, The New England journal of medicine.

[12]  S. Kanner,et al.  Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. , 1997, Blood.

[13]  B. Margolis,et al.  Wiskott-Aldrich syndrome protein is associated with the adapter protein Grb2 and the epidermal growth factor receptor in living cells. , 1997, Molecular biology of the cell.

[14]  F. Finkelman,et al.  Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients. , 1997, Journal of immunology.

[15]  M. Yamada,et al.  Mutation Analysis of Five Japanese Families with Wiskott-Aldrich Syndrome and Determination of the Family Members' Carrier Status Using Three Different Methods , 1997, Pediatric Research.

[16]  M. Yamada,et al.  Detection of a novel splice-site mutation that results in skipping exon 3 of the WASP gene in a patient with Wiskott-Aldrich syndrome. , 1996, Biochimica et biophysica acta.

[17]  K. Siminovitch,et al.  Identification of WASP mutations, mutation hotspots and genotype-phenotype disparities in 24 patients with the Wiskott-Aldrich syndrome , 1996, Human Genetics.

[18]  R C Lovering,et al.  Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. , 1996, Journal of immunology.

[19]  K. Miura,et al.  N‐WASP, a novel actin‐depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2‐dependent manner downstream of tyrosine kinases. , 1996, The EMBO journal.

[20]  L. Maquat.  Defects in RNA splicing and the consequence of shortened translational reading frames. , 1996, American journal of human genetics.

[21]  I. Gout,et al.  Wiskott–Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases , 1996, Current Biology.

[22]  K. Schwarz,et al.  Isolated X-linked thrombocytopenia in two unrelated families is associated with point mutations in the Wiskott-Aldrich syndrome protein gene. , 1996, The Journal of pediatrics.

[23]  L. Notarangelo,et al.  Studies of the expression of the Wiskott-Aldrich syndrome protein. , 1996, The Journal of clinical investigation.

[24]  J. Schlessinger,et al.  PH Domains: Diverse Sequences with a Common Fold Recruit Signaling Molecules to the Cell Surface , 1996, Cell.

[25]  A. Meindl,et al.  Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product , 1996, Human Genetics.

[26]  T. Kirchhausen,et al.  Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Schwartz,et al.  Mutation Spectrum in Patients with Wiskott-Aldrich Syndrome and X-linked Thrombocytopenia: Identification of Twelve Different Mutations in the WASP Gene , 1996, Thrombosis and Haemostasis.

[28]  E. Remold-O’Donnell,et al.  Defects in Wiskott-Aldrich syndrome blood cells. , 1996, Blood.

[29]  U. Francke,et al.  Wiskott–Aldrich Syndrome Protein, a Novel Effector for the GTPase CDC42Hs, Is Implicated in Actin Polymerization , 1996, Cell.

[30]  U. Francke,et al.  The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. , 1995, Blood.

[31]  A. Marcilla,et al.  Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains , 1995, Molecular and cellular biology.

[32]  R. Blaese,et al.  Scanning of the Wiskott-Aldrich syndrome (WAS) gene: identification of 18 novel alterations including a possible mutation hotspot at Arg86 resulting in thrombocytopenia, a mild WAS phenotype. , 1995, Human molecular genetics.

[33]  L. Maquat.  When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. , 1995, RNA.

[34]  X. Estivill,et al.  WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. , 1995, Human molecular genetics.

[35]  S. Weissman,et al.  Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus. , 1995, Human molecular genetics.

[36]  R. Blaese,et al.  Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  U. Francke,et al.  Isolation of a novel gene mutated in Wiskott-Aldrich syndrome , 1994, Cell.

[38]  P. Hwang,et al.  A Case of Wiskott-Aldrich Syndrome , 1993 .

[39]  David Valle,et al.  The skipping of constitutive exons in vivo induced by nonsense mutations , 1993, Science.

[40]  L. Harker,et al.  The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets , 1980 .

[41]  Aldrich Ra,et al.  Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. , 1954 .

[42]  S. Antonarakis.  Recommendations for a nomenclature system for human gene mutations , 1998 .

[43]  Uno Lindberg,et al.  Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott–Aldrich syndrome , 1996, Current Biology.

[44]  P. Sharp,et al.  Splicing of messenger RNA precursors. , 1987, Science.